CD274 and neoplasm: The therapeutic efficacy of the novel Measles Schwarz vaccine strain vectors encoding IL-12 fusion protein (MeVac FmIL-12) and an antibody against PD-L1 (MeVac anti-PD-L1), was evaluated in the immunocompetent MC38cea tumour model [209].